MANNITOL
Cardiac Event
Baylor Research InstituteSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Cardiac Event cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Degarelix Rabin Medical Center | Phase 4 | BBB |
AIR Turku University Hospital | Phase 2 | CCC |
XENON Turku University Hospital | Phase 2 | CCC |
Xinmailong Peking Union Medical College | Phase 2 | CCC |
Oxygen Turku University Hospital | Phase 2 | CCC |
LACTULOSE Baylor Research Institute | N/A | D |
Sucralose Baylor Research Institute | N/A | D |
Same molecule, other indications
MANNITOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →